Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

L Kappos, D Bates, G Edan, M Eraksoy… - The Lancet …, 2011 - thelancet.com
Natalizumab, a highly specific α4-integrin antagonist, is approved for treatment of patients
with active relapsing-remitting multiple sclerosis (RRMS). It is generally recommended for …

[HTML][HTML] The role of polyomaviruses in human disease

M Jiang, JR Abend, SF Johnson, MJ Imperiale - Virology, 2009 - Elsevier
The human polyomaviruses, BK virus and JC virus, have long been associated with serious
diseases including polyomavirus nephropathy and progressive multifocal …

[PDF][PDF] A WHO reference reagent to standardise haemagglutination testing for anti-A and anti-B in serum and plasma: Report of the international collaborative study to …

World Health Organization… - 2015 - apps.who.int
A lyophilised serum preparation with high anti-A and anti-B titres, 14/300, was evaluated for
its suitability to serve as a WHO Reference Reagent to standardise and control …

[HTML][HTML] Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents

JE Kaplan, C Benson, KK Holmes, JT Brooks, A Pau… - MMWR Recomm …, 2009 - cdc.gov
This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …

Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease

EL Murphy, AC Collier, LA Kalish… - Annals of internal …, 2001 - acpjournals.org
Background: Mortality and morbidity related to AIDS have decreased among HIV-infected
patients taking highly active anti-retroviral therapy (HAART), but previous studies may have …

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

K Tan, R Roda, L Ostrow, J McArthur, A Nath - Neurology, 2009 - neurology.org
Background: Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection
that develops in immunosuppressed patients with HIV infection. Paradoxically, some of …

Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)

M Maschke, O Kastrup, S Esser, B Ross… - Journal of Neurology …, 2000 - jnnp.bmj.com
OBJECTIVE To determine the change of incidence and prevalence of neurological disorders
caused by the human immunodeficiency virus (HIV) and opportunistic infections in HIV …

Progressive multifocal leukoencephalopathy and other forms of JC virus disease

BJ Brew, NWS Davies, P Cinque, DB Clifford… - Nature Reviews …, 2010 - nature.com
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the brain
caused by the JC virus (JCV). PML usually occurs via reactivation of JCV when an immune …

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

BO Khatri, S Man, G Giovannoni, AP Koo, JC Lee… - Neurology, 2009 - neurology.org
Background: Accelerating the clearance of therapeutic monoclonal antibodies (mAbs) from
the body may be useful to address uncommon but serious complications from treatment …

Progressive multifocal leukoencephalopathy in HIV-1 infection

P Cinque, IJ Koralnik, S Gerevini, JM Miro… - The Lancet infectious …, 2009 - thelancet.com
Progressive multifocal leukoencephalopathy is caused by the JC polyomavirus (JCV) and is
one of the most feared complications of HIV-1 infection. Unlike other opportunistic infections …